| LIDOX | OAYIX | LIDOX / OAYIX | |
| Total Expense Ratio | 0.66 | 0.88 | 75% |
| Annual Report Gross Expense Ratio | 0.66 | 0.88 | 75% |
| Fund Existence | 9 years | 9 years | - |
| Gain YTD | 27.226 | 29.832 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 462M | 14.6B | 3% |
| Annual Yield % from dividends | 3.06 | 2.13 | 144% |
| Returns for 1 year | 22.85 | 22.85 | 100% |
| Returns for 3 years | 80.04 | 65.84 | 122% |
| Returns for 5 years | 72.45 | 64.55 | 112% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DZZ | 2.66 | 0.67 | +33.67% |
| DB Gold Double Short ETN | |||
| RWX | 28.12 | 0.18 | +0.65% |
| SPDR® Dow Jones® International RelEstETF | |||
| ICAP | 27.23 | -0.06 | -0.22% |
| Infrastructure Capital Equity Income ETF | |||
| ENDW | 30.32 | -0.07 | -0.24% |
| Cambria Endowment Style ETF | |||
| ARKG | 30.57 | -2.09 | -6.40% |
| ARK Genomic Revolution ETF | |||